Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Equity Ratio (2020 - 2025)

Historic Equity Ratio for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to 0.17.

  • NeuroPace's Equity Ratio rose 6926.7% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 6926.7%. This contributed to the annual value of 0.08 for FY2024, which is 5587.32% down from last year.
  • NeuroPace's Equity Ratio amounted to 0.17 in Q3 2025, which was up 6926.7% from 0.18 recorded in Q2 2025.
  • NeuroPace's Equity Ratio's 5-year high stood at 0.6 during Q2 2021, with a 5-year trough of 3.11 in Q1 2021.
  • In the last 5 years, NeuroPace's Equity Ratio had a median value of 0.21 in 2023 and averaged 0.11.
  • As far as peak fluctuations go, NeuroPace's Equity Ratio surged by 12082.83% in 2021, and later crashed by 5587.32% in 2024.
  • Quarter analysis of 5 years shows NeuroPace's Equity Ratio stood at 0.55 in 2021, then crashed by 44.62% to 0.3 in 2022, then crashed by 37.05% to 0.19 in 2023, then tumbled by 55.87% to 0.08 in 2024, then skyrocketed by 103.93% to 0.17 in 2025.
  • Its Equity Ratio was 0.17 in Q3 2025, compared to 0.18 in Q2 2025 and 0.22 in Q1 2025.